Beneficial Effects of (pGlu-Gln)-CCK-8 on Energy Intake and Metabolism in High Fat Fed Mice are Associated with Alterations of Hypothalamic Gene Expression.

IA Montgomery; Nigel Irwin; Peter Flatt

doi:10.1055/s-0032-1331767

Beneficial Effects of (pGlu-Gln)-CCK-8 on Energy Intake and Metabolism in High Fat Fed Mice are Associated with Alterations of Hypothalamic Gene Expression.

IA Montgomery
, Nigel Irwin
, Peter Flatt

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

Cholecystokinin (CCK) is a gastrointestinal hormone with potential therapeutic promise for obesity-diabetes. The present study examined the effects of twice daily administration of the N-terminally modified stable CCK-8 analogue, (pGlu-Gln)-CCK-8, on metabolic control and hypothalamic gene expression in high fat fed mice. Sub-chronic twice daily injection of (pGlu-Gln)-CCK-8 for 16 days significantly decreased body weight (p

Original language	English
Pages (from-to)	471-473
Journal	HORMONE AND METABOLIC RESEARCH
Volume	45
Issue number	6
DOIs	https://doi.org/10.1055/s-0032-1331767
Publication status	Published (in print/issue) - 11 Jan 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1055/s-0032-1331767

Cite this

@article{c725d6d316894b57a7fbf27bbe5633a9,

title = "Beneficial Effects of (pGlu-Gln)-CCK-8 on Energy Intake and Metabolism in High Fat Fed Mice are Associated with Alterations of Hypothalamic Gene Expression.",

abstract = "Cholecystokinin (CCK) is a gastrointestinal hormone with potential therapeutic promise for obesity-diabetes. The present study examined the effects of twice daily administration of the N-terminally modified stable CCK-8 analogue, (pGlu-Gln)-CCK-8, on metabolic control and hypothalamic gene expression in high fat fed mice. Sub-chronic twice daily injection of (pGlu-Gln)-CCK-8 for 16 days significantly decreased body weight (p",

author = "IA Montgomery and Nigel Irwin and Peter Flatt",

year = "2013",

month = jan,

day = "11",

doi = "10.1055/s-0032-1331767",

language = "English",

volume = "45",

pages = "471--473",

journal = "HORMONE AND METABOLIC RESEARCH",

issn = "1439-4286",

publisher = "Georg Thieme Verlag",

number = "6",

}

TY - JOUR

T1 - Beneficial Effects of (pGlu-Gln)-CCK-8 on Energy Intake and Metabolism in High Fat Fed Mice are Associated with Alterations of Hypothalamic Gene Expression.

AU - Montgomery, IA

AU - Irwin, Nigel

AU - Flatt, Peter

PY - 2013/1/11

Y1 - 2013/1/11

N2 - Cholecystokinin (CCK) is a gastrointestinal hormone with potential therapeutic promise for obesity-diabetes. The present study examined the effects of twice daily administration of the N-terminally modified stable CCK-8 analogue, (pGlu-Gln)-CCK-8, on metabolic control and hypothalamic gene expression in high fat fed mice. Sub-chronic twice daily injection of (pGlu-Gln)-CCK-8 for 16 days significantly decreased body weight (p

AB - Cholecystokinin (CCK) is a gastrointestinal hormone with potential therapeutic promise for obesity-diabetes. The present study examined the effects of twice daily administration of the N-terminally modified stable CCK-8 analogue, (pGlu-Gln)-CCK-8, on metabolic control and hypothalamic gene expression in high fat fed mice. Sub-chronic twice daily injection of (pGlu-Gln)-CCK-8 for 16 days significantly decreased body weight (p

U2 - 10.1055/s-0032-1331767

DO - 10.1055/s-0032-1331767

M3 - Article

SN - 1439-4286

VL - 45

SP - 471

EP - 473

JO - HORMONE AND METABOLIC RESEARCH

JF - HORMONE AND METABOLIC RESEARCH

IS - 6

ER -

Beneficial Effects of (pGlu-Gln)-CCK-8 on Energy Intake and Metabolism in High Fat Fed Mice are Associated with Alterations of Hypothalamic Gene Expression.

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this